Cleared Special

FilmArray Blood Culture Identification (BCID) Panel

K181493 · Biofire Diagnostics, LLC · Microbiology
Jul 2018
Decision
29d
Days
Class 2
Risk

About This 510(k) Submission

K181493 is an FDA 510(k) clearance for the FilmArray Blood Culture Identification (BCID) Panel, a Gram-negative Bacteria And Associated Resistance Markers (Class II — Special Controls, product code PEN), submitted by Biofire Diagnostics, LLC (Salt Lake City, US). The FDA issued a Cleared decision on July 5, 2018, 29 days after receiving the submission on June 6, 2018. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3365.

Submission Details

510(k) Number K181493 FDA.gov
FDA Decision Cleared SESE
Date Received June 06, 2018
Decision Date July 05, 2018
Days to Decision 29 days
Submission Type Special
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code PEN — Gram-negative Bacteria And Associated Resistance Markers
Device Class Class II — Special Controls
CFR Regulation 21 CFR 866.3365
Definition A Qualitative Multiplexed In Vitro Diagnostic Device To Detect And Identify Gram-negative Bacteria And Resistance Markers In Positive Blood Cultures.

Similar Devices — PEN Gram-negative Bacteria And Associated Resistance Markers

All 10
LIAISON PLEX Gram-Negative Blood Culture Assay
K243013 · Luminex Corporation · Apr 2025
BIOFIRE Blood Culture Identification 2 (BCID2) Panel (RFIT-ASY-0147 (30 pack) RFIT-ASY-0148 (6 pack))
K243759 · Biofire Diagnostics, LLC · Dec 2024
ePlex Blood Culture Identification Gram Negative (BCID-GN) Panel
K213236 · Genmark Diagnostics, Incorporated · Apr 2022
BioFire Blood Culture Identification 2 (BCID2) Panel
K193519 · Biofire Diagnostics, LLC · Mar 2020
iC-GN iC-Cassette for use on the iC-System
K190341 · Icubate, Inc. · Jun 2019
ePlex Blood Culture Identification Gram Negative (BCID-GN) Panel
K182619 · Genmark Diagnostics, Incorporated · Apr 2019